ENDRA LIFE SCIENCES INC. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows, 20 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-10-10: Reporting owner DIGIANDOMENICO ANTHONY; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-05-02: Reporting owner DIGIANDOMENICO ANTHONY; Form 4; Security Warrants; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2020-07-21: Reporting owner DIGIANDOMENICO ANTHONY; Form 4; Security Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2020-07-15: Reporting owner Thornton Michael Milos; Form 4; Security Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
NDRA insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-10 | DIGIANDOMENICO ANTHONY Director | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +141,644 141,644 owned after | $7.06 | $6.48 | 2025-10-15 |
| 2023-05-02 | DIGIANDOMENICO ANTHONY Director | 4 | Warrants Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +41,667 41,667 owned after | $0.01 | $2,975.00 | 2023-05-03 |
| 2020-07-21 | DIGIANDOMENICO ANTHONY Director | 4 | Warrants Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −100,503 0 owned after | $0.87 exercise price | $35,000.00 | 2020-07-23 |
| 2020-07-15 | Thornton Michael Milos Officer (Chief Technology Officer) | 4 | Warrants Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −26,000 24,252 owned after | $0.87 exercise price | $31,290.00 | 2020-07-16 |
| 2020-06-23 | Harsh Michael Director | 4 | Warrants Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −5,000 6,056 owned after | $0.87 exercise price | $36,050.00 | 2020-06-24 |
| 2020-06-23 | Wells David R. Officer (Chief Financial Officer) | 4 | Warrants Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −5,000 5,051 owned after | $0.87 exercise price | $36,050.00 | 2020-06-24 |
| 2020-06-23 | Michelon Francois Roger Director, Officer (Chief Executive Officer) | 4 | Warrants Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −2,874 2,152 owned after | $0.87 exercise price | $36,050.00 | 2020-06-24 |
| 2019-12-11 | Wells David R. Officer (Chief Financial Officer) | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,051 10,051 owned after | $0.87 exercise price | $31,500.00 | 2019-12-11 |
| 2019-12-11 | Thornton Michael Milos Officer (Chief Technology Officer) | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,252 50,252 owned after | $0.87 exercise price | $31,500.00 | 2019-12-11 |
| 2019-12-11 | Michelon Francois Roger Director, Officer (Chief Executive Officer) | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,026 5,026 owned after | $0.87 exercise price | $31,500.00 | 2019-12-11 |
| 2019-12-11 | Harsh Michael Director | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,056 11,056 owned after | $0.87 exercise price | $31,500.00 | 2019-12-11 |
| 2019-12-11 | DIGIANDOMENICO ANTHONY Director | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,503 100,503 owned after | $0.87 exercise price | $31,500.00 | 2019-12-11 |
| 2018-06-28 | DIGIANDOMENICO ANTHONY Director | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | $2.52 exercise price | $99,050.00 | 2018-07-02 | |
| 2018-06-28 | Wells David R. Officer (Chief Financial Officer) | 4 | Warrants Derivative · Indirect · By StoryCorp Consulting | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | $2.52 exercise price | $99,050.00 | 2018-07-02 | |
| 2018-06-28 | Thornton Michael Milos Officer (Chief Technology Officer) | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | $2.52 exercise price | $99,050.00 | 2018-07-02 | |
| 2018-06-28 | Michelon Francois Roger Director, Officer (Chief Executive Officer) | 4 | Warrants Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | $2.52 exercise price | $99,050.00 | 2018-07-02 | |
| 2018-04-19 holding as of filing | Longboard Capital Advisors, LLC | Conrad Brett 10% Owner | 10% Owner | 3 | Warrants Derivative · Indirect · See footnote | Holding | $20.03 exercise price | 2018-04-19 | ||
| 2018-04-19 holding as of filing | Longboard Capital Advisors, LLC | Conrad Brett 10% Owner | 10% Owner | 3 | Warrants Derivative · Indirect · See footnote | Holding | $6.25 exercise price | 2018-04-19 | ||
| 2017-05-19 holding as of filing | DIGIANDOMENICO ANTHONY Director | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $20.02 exercise price | 2017-05-19 | ||
| 2017-05-16 holding as of filing | Thornton Michael Milos Officer (Chief Technology Officer) | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $20.02 exercise price | 2017-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |